Skip to content

Welcome to Discover Pharma! Today is : November 7, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Advanced Therapies

  • Advanced Therapies,Biotech & Pharma Business,Drug Delivery & Formulation,Drug Discovery & Development,Manufacturing & Supply Chain

    LNP pioneer Pieter Cullis joins Hongene’s scientific advisory board

    Hongene has appointed leading lipid nanoparticle (LNP) researcher Pieter Cullis [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Opinion & Events

    Ethris begins Phase 2a trial of intranasal mRNA candidate ETH47 for virus-triggered asthma

    Ethris has dosed the first patient in a Phase 2a [...]

    May 5, 2026
  • Advanced Therapies,Therapeutic Areas

    Broken String renews NIST gene editing safety push with INDUCE-seq technology

    Broken String Biosciences has reaffirmed its commitment to supporting the [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Elsevier launches Reaxys AI Search to support faster chemical discovery and interdisciplinary R&D

    New natural language capability aims to reduce barriers for researchers [...]

    May 5, 2026
  • Advanced Therapies,Digital & Data,Drug Discovery & Development

    Latent Labs unveils AI model Latent-X for instant, lab-validated protein binder design

    No-code platform opens early access to generative binder design with [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development

    Meitheal strengthens leadership team with new chief medical officer and head of medical affairs

    Appointments reflect strategic focus on infectious disease and medical affairs [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain

    PL BioScience opens new headquarters to support growing demand for HPL production

    1,200 m² Aachen facility will enable largest global HPL output [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain,Therapeutic Areas

    University of Minnesota investigators awarded $665,000 in ScaleReady G-Rex Grant funding

    Three research teams to advance manufacturing and development of cell [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain

    Nearly three-quarters of scientists expect a recession – but most still plan to spend LINUS survey reveals

    Despite political and economic pressures, researchers remain focused on collaboration, [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain

    Symbiosis completes 1,000th batch of sterile injectable drug product

    Contract manufacturer Symbiosis Pharmaceutical Services has announced the completion of [...]

    May 5, 2026
Previous222324Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • $3M funding targets tau-driven neurodegenerative diseases
    Categories: Central Nervous System, Drug Discovery & Development, Research & Development, Therapeutic Areas
  • Cancer vaccine research secures $2.5M NIH award for nanoparticle treatment
    Categories: Drug Delivery & Formulation, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • FDA approves Protagonist’s Mimrylo for polycythemia vera, triggering $275M in payments
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top